News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Vaishnaw Akshay
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/07/2023 |
4
| Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 5,082 shares
@ $0 Granted 3,859 shares
@ $0 Sold 771 shares
@ $184.7, valued at
$142.4k
Sold 1,869 shares
@ $185.54, valued at
$346.8k
Sold 1,107 shares
@ $186.39, valued at
$206.3k
Sold 101 shares
@ $187.37, valued at
$18.9k
Sold 17 shares
@ $188.4, valued at
$3.2k
Sold 192 shares
@ $189.31, valued at
$36.3k
|
|
04/28/2023 |
4
| Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 5,312 shares
@ $0 Sold 197 shares
@ $193.18, valued at
$38.1k
Sold 910 shares
@ $193.93, valued at
$176.5k
Sold 1,013 shares
@ $194.94, valued at
$197.5k
Sold 104 shares
@ $195.65, valued at
$20.3k
Sold 168 shares
@ $197.08, valued at
$33.1k
|
|
03/01/2023 |
4
| Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 5,790 restricted stock units
@ $0 Granted 11,986 options to buy
@ $190.01, valued at
$2.3M
|
|
02/14/2023 |
4
| Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Sold 1,709 shares
@ $213.13, valued at
$364.2k
Sold 2,307 shares
@ $214.28, valued at
$494.3k
Sold 10,279 shares
@ $215.59, valued at
$2.2M
Sold 19,447 shares
@ $216.38, valued at
$4.2M
Sold 4,302 shares
@ $217.05, valued at
$933.7k
Exercised 30,913 options to buy
@ $63, valued at
$1.9M
|
|
12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 14,000 options to buy
@ $4.86, valued at
$68k
|
|
06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2022 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 28,000 options to buy
@ $4.75, valued at
$133k
|
|
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2022 |
4
| Vaishnaw Akshay (President) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 22,380 options to buy
@ $169.58, valued at
$3.8M
|
|
12/23/2021 |
4
| Vaishnaw Akshay (President, R&D) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 5,417 shares
@ $0 Paid exercise price by delivering 2,415 shares
@ $189.13, valued at
$456.7k
Paid exercise price by delivering 1 shares
@ $190.5, valued at
$190.5 Paid exercise price by delivering 122 shares
@ $186.48, valued at
$22.8k
Sold 124 shares
@ $186.22, valued at
$23.1k
Sold 137 shares
@ $187.08, valued at
$25.6k
Sold 130 shares
@ $187.35, valued at
$24.4k
Sold 127 shares
@ $188.26, valued at
$23.9k
Sold 73 shares
@ $189.01, valued at
$13.8k
Sold 8 shares
@ $189.18, valued at
$1.5k
Sold 144 shares
@ $189.24, valued at
$27.3k
|
|
08/11/2021 |
4
| Vaishnaw Akshay (President, R&D) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Sold 10,834 shares
@ $200, valued at
$2.2M
Exercised 10,834 options to buy
@ $63, valued at
$682.5k
|
|
06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2021 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Editas Medicine, Inc.
Txns:
| Granted 11,538 options to buy
@ $33.36, valued at
$384.9k
|
|
06/01/2021 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 7,800 options to buy
@ $26.78, valued at
$208.9k
|
|
04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2020 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 13,000 options to buy
@ $17.65, valued at
$229.5k
|
|
06/12/2020 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Editas Medicine, Inc.
Txns:
| Granted 11,538 options to buy
@ $27.49, valued at
$317.2k
|
|
04/22/2020 |
4
| Vaishnaw Akshay (President, R&D) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Sold 21,971 shares
@ $140, valued at
$3.1M
Exercised 21,000 options to buy
@ $42.22, valued at
$886.6k
Exercised 971 options to buy
@ $42.22, valued at
$41k
|
|
04/09/2020 |
4
| Vaishnaw Akshay (President, R&D) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 5,417 shares
@ $0 Paid exercise price by delivering 2,415 shares
@ $104.75, valued at
$253k
Paid exercise price by delivering 98 shares
@ $106.52, valued at
$10.4k
|
|
02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/26/2019 |
4
| Vaishnaw Akshay (President, R&D) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Granted 8,333 options to buy
@ $119.13, valued at
$992.7k
|
|
08/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2019 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Editas Medicine, Inc.
Txns:
| Granted 11,538 options to buy
@ $21.74, valued at
$250.8k
|
|
06/07/2019 |
4
| Vaishnaw Akshay (President, R&D) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.
Txns:
| Acquired 21 shares
@ $0 Acquired 51 shares
@ $0 Granted 6,250 options to buy
@ $42.22, valued at
$263.9k
|
|
05/23/2019 |
4
| Vaishnaw Akshay (Director) has filed a Form 4 on Scholar Rock Holding Corp
Txns:
| Granted 20,316 options to buy
@ $21.21, valued at
$430.9k
|
|
03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|